481 related articles for article (PubMed ID: 32578483)
21. Additional Diagnostic Value of Growth Differentiation Factor-15 (GDF-15) to N-Terminal B-Type Natriuretic Peptide (NT-proBNP) in Patients with Different Stages of Heart Failure.
Li J; Cui Y; Huang A; Li Q; Jia W; Liu K; Qi X
Med Sci Monit; 2018 Jul; 24():4992-4999. PubMed ID: 30019695
[TBL] [Abstract][Full Text] [Related]
22. GDF-15: a novel biomarker of heart failure predicts short-term and long-term heart-failure rehospitalization and short-term mortality in patients with acute heart failure syndrome.
Kosum P; Siranart N; Mattanapojanat N; Phutinart S; Kongruttanachok N; Sinphurmsukskul S; Siwamogsatham S; Puwanant S; Ariyachaipanich A
BMC Cardiovasc Disord; 2024 Mar; 24(1):151. PubMed ID: 38475710
[TBL] [Abstract][Full Text] [Related]
23. Growth differentiation factor 15, ST2, high-sensitivity troponin T, and N-terminal pro brain natriuretic peptide in heart failure with preserved vs. reduced ejection fraction.
Santhanakrishnan R; Chong JP; Ng TP; Ling LH; Sim D; Leong KT; Yeo PS; Ong HY; Jaufeerally F; Wong R; Chai P; Low AF; Richards AM; Lam CS
Eur J Heart Fail; 2012 Dec; 14(12):1338-47. PubMed ID: 22869458
[TBL] [Abstract][Full Text] [Related]
24. Association of Multiple Biomarkers With Risk of All-Cause and Cause-Specific Mortality After Acute Coronary Syndromes: A Secondary Analysis of the PLATO Biomarker Study.
Lindholm D; James SK; Gabrysch K; Storey RF; Himmelmann A; Cannon CP; Mahaffey KW; Steg PG; Held C; Siegbahn A; Wallentin L
JAMA Cardiol; 2018 Dec; 3(12):1160-1166. PubMed ID: 30427997
[TBL] [Abstract][Full Text] [Related]
25. Variability of biomarkers in patients with chronic heart failure and healthy controls.
Meijers WC; van der Velde AR; Muller Kobold AC; Dijck-Brouwer J; Wu AH; Jaffe A; de Boer RA
Eur J Heart Fail; 2017 Mar; 19(3):357-365. PubMed ID: 27766733
[TBL] [Abstract][Full Text] [Related]
26. Multimarker Risk Stratification in Patients With Acute Myocardial Infarction.
O'Donoghue ML; Morrow DA; Cannon CP; Jarolim P; Desai NR; Sherwood MW; Murphy SA; Gerszten RE; Sabatine MS
J Am Heart Assoc; 2016 May; 5(5):. PubMed ID: 27207959
[TBL] [Abstract][Full Text] [Related]
27. Profiles of cardiovascular biomarkers according to severity stages of Chagas cardiomyopathy.
Echeverría LE; Rojas LZ; Calvo LS; Roa ZM; Rueda-Ochoa OL; Morillo CA; Muka T; Franco OH
Int J Cardiol; 2017 Jan; 227():577-582. PubMed ID: 27839809
[TBL] [Abstract][Full Text] [Related]
28. Clinical and Biomarker Predictors of Expanded Heart Failure Outcomes in Patients With Type 2 Diabetes Mellitus After a Recent Acute Coronary Syndrome: Insights From the EXAMINE Trial.
Sharma A; Vaduganathan M; Ferreira JP; Liu Y; Bakris GL; Cannon CP; White WB; Zannad F
J Am Heart Assoc; 2020 Jan; 9(1):e012797. PubMed ID: 31902327
[TBL] [Abstract][Full Text] [Related]
29. Cystatin C-based CKD-EPI equations and N-terminal pro-B-type natriuretic peptide for predicting outcomes in acutely decompensated heart failure.
Flores-Blanco PJ; Manzano-Fernández S; Pérez-Calvo JI; Pastor-Pérez FJ; Ruiz-Ruiz FJ; Carrasco-Sánchez FJ; Morales-Rull JL; Pascual-Figal D; Galisteo-Almeda L; Januzzi JL
Clin Cardiol; 2015 Feb; 38(2):106-13. PubMed ID: 25663560
[TBL] [Abstract][Full Text] [Related]
30. The influence of atrial fibrillation on the levels of NT-proBNP versus GDF-15 in patients with heart failure.
Santema BT; Chan MMY; Tromp J; Dokter M; van der Wal HH; Emmens JE; Takens J; Samani NJ; Ng LL; Lang CC; van der Meer P; Ter Maaten JM; Damman K; Dickstein K; Cleland JG; Zannad F; Anker SD; Metra M; van der Harst P; de Boer RA; van Veldhuisen DJ; Rienstra M; Lam CSP; Voors AA
Clin Res Cardiol; 2020 Mar; 109(3):331-338. PubMed ID: 31263996
[TBL] [Abstract][Full Text] [Related]
31. Natriuretic Peptide Response and Outcomes in Chronic Heart Failure With Reduced Ejection Fraction.
Januzzi JL; Ahmad T; Mulder H; Coles A; Anstrom KJ; Adams KF; Ezekowitz JA; Fiuzat M; Houston-Miller N; Mark DB; Piña IL; Passmore G; Whellan DJ; Cooper LS; Leifer ES; Desvigne-Nickens P; Felker GM; O'Connor CM
J Am Coll Cardiol; 2019 Sep; 74(9):1205-1217. PubMed ID: 31466618
[TBL] [Abstract][Full Text] [Related]
32. Long-term trajectory of two unique cardiac biomarkers and subsequent left ventricular structural pathology and risk of incident heart failure in community-dwelling older adults at low baseline risk.
Glick D; deFilippi CR; Christenson R; Gottdiener JS; Seliger SL
JACC Heart Fail; 2013 Aug; 1(4):353-360. PubMed ID: 24621939
[TBL] [Abstract][Full Text] [Related]
33. Biomarkers of chronic cardiac injury and hemodynamic stress identify a malignant phenotype of left ventricular hypertrophy in the general population.
Neeland IJ; Drazner MH; Berry JD; Ayers CR; deFilippi C; Seliger SL; Nambi V; McGuire DK; Omland T; de Lemos JA
J Am Coll Cardiol; 2013 Jan; 61(2):187-95. PubMed ID: 23219305
[TBL] [Abstract][Full Text] [Related]
34. Diagnostic performance and reference values of novel biomarkers of paediatric heart failure.
Hauser JA; Demyanets S; Rusai K; Goritschan C; Weber M; Panesar D; Rindler L; Taylor AM; Marculescu R; Burch M; Wojta J; Michel-Behnke I
Heart; 2016 Oct; 102(20):1633-9. PubMed ID: 27220692
[TBL] [Abstract][Full Text] [Related]
35. MicroRNAs are associated with cardiac biomarkers, cardiac structure and function and incident outcomes in heart failure.
Spahillari A; Jackson L; Varrias D; Michelhaugh SA; Januzzi JL; Shahideh B; Daghfal D; Valkov N; Murtagh G; Das S
ESC Heart Fail; 2024 Jun; 11(3):1400-1410. PubMed ID: 38321808
[TBL] [Abstract][Full Text] [Related]
36. Circulating levels and prognostic value of soluble ST2 in heart failure are less influenced by age than N-terminal pro-B-type natriuretic peptide and high-sensitivity troponin T.
Aimo A; Januzzi JL; Vergaro G; Richards AM; Lam CSP; Latini R; Anand IS; Cohn JN; Ueland T; Gullestad L; Aukrust P; Brunner-La Rocca HP; Bayes-Genis A; Lupón J; de Boer RA; Takeishi Y; Egstrup M; Gustafsson I; Gaggin HK; Eggers KM; Huber K; Gamble GD; Ling LH; Leong KTG; Yeo PSD; Ong HY; Jaufeerally F; Ng TP; Troughton R; Doughty RN; Passino C; Emdin M
Eur J Heart Fail; 2020 Nov; 22(11):2078-2088. PubMed ID: 31919929
[TBL] [Abstract][Full Text] [Related]
37. Associations of N-terminal pro-B-type natriuretic peptide with kidney function decline in persons without clinical heart failure in the Heart and Soul Study.
Park M; Vittinghoff E; Shlipak MG; Mishra R; Whooley M; Bansal N
Am Heart J; 2014 Dec; 168(6):931-9.e2. PubMed ID: 25458658
[TBL] [Abstract][Full Text] [Related]
38. Blood-Based Cardiac Biomarkers and the Risk of Cognitive Decline, Cerebrovascular Disease, and Clinical Events.
Gyanwali B; Lai MKP; Lui B; Liew OW; Venketasubramanian N; Richards AM; Chen C; Hilal S
Stroke; 2021 Jul; 52(7):2275-2283. PubMed ID: 33971742
[TBL] [Abstract][Full Text] [Related]
39. Midregional proadrenomedullin and growth differentiation factor-15 are not influenced by obesity in heart failure patients.
Sinning C; Ojeda F; Wild PS; Schnabel RB; Schwarzl M; Ohdah S; Lackner KJ; Pfeiffer N; Michal M; Blettner M; Munzel T; Kempf T; Wollert KC; Kuulasmaa K; Blankenberg S; Salomaa V; Westermann D; Zeller T
Clin Res Cardiol; 2017 Jun; 106(6):401-410. PubMed ID: 28004184
[TBL] [Abstract][Full Text] [Related]
40. Changes in cardiac biomarkers in association with alterations in cardiac structure and function, and health status in heart failure with reduced ejection fraction: the EVALUATE-HF trial.
Myhre PL; Claggett BL; Shah AM; Prescott MF; Ward JH; Fang JC; Mitchell GF; Solomon SD; Desai AS
Eur J Heart Fail; 2022 Jul; 24(7):1200-1208. PubMed ID: 35560696
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]